Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
301 - 350 out of 794Page size: 50

Publications

  1. 2018

  2. Die medikamentöse onkologische Therapie im Wandel - Aufbau von Strukturen zur Patientenversorgung

    Velthaus, J-L., Bokemeyer, C. & Loges, S., 06.2018, In: InFo Onkologie. 21, S1, p. 10-18

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  3. Personalisierte Krebstherapie 2018 - Fiktion oder Wirklichkeit?

    Loges, S. & Bokemeyer, C., 06.2018, In: InFo Onkologie. 21 , S1, p. 3-5

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  4. Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors

    Seidel, C., Daugaard, G., Tryakin, A., Necchi, A., Cohn Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K. & Bokemeyer, C., 05.2018, In: EUR J CANCER. 94, p. 16-25 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. Therapeutic approaches for refractory germ cell cancer

    Oing, C., Seidel, C. & Bokemeyer, C., 04.2018, In: EXPERT REV ANTICANC. 18, 4, p. 389-397 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  6. Synthesis and anticancer activity of the derivatives of marine compound rhizochalin in castration resistant prostate cancer

    Dyshlovoy, S. A., Otte, K., Tabakmakher, K. M., Hauschild, J., Makarieva, T. N., Shubina, L. K., Fedorov, S. N., Bokemeyer, C., Stonik, V. A. & von Amsberg, G., 30.03.2018, In: ONCOTARGET. 9, 24, p. 16962-16973 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial

    Scholl, I., Hahlweg, P., Lindig, A., Bokemeyer, C., Coym, A., Hanken, H., Müller, V., Smeets, R., Witzel, I., Kriston, L. & Härter, M., 27.03.2018, In: IMPLEMENT SCI. 13, 1, p. 51

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy

    Schliffke, S., Sivina, M., Kim, E., Wenserski, L. V., Thiele, B., Akyüz, N., Falker-Gieske, C., Statovci, D., Oberle, A., Thenhausen, T., Krohn-Grimberghe, A., Bokemeyer, C., Jain, N., Estrov, Z., Ferrajoli, A., Wierda, W., Keating, M., Burger, J. A. & Binder, M., 15.01.2018, In: ONCOIMMUNOLOGY. 7, 4, p. e1417720

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Der ältere Krebspatient - Herausforderungen im Krankenhaus und in der Praxis

    Bokemeyer, C., Busse, R., Engel, J., Gebauer, A., Hallek, M., Heinemann, V., Lüftner, D. & Wörmann, B., 2018, In: ONCOL RES TREAT. 41 Suppl 3, p. 2-26 25 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Gastointestinale Stromatumoren (GIST)

    Kopp, H-G., Bokemeyer, C. & Hohenberger, P., 2018, Taschenbuch Onkologie: Interdisziplinäre Empfehlungen zur Therapie 2018/2019. Honecker, F., Claßen, J., Preiß, J. & Dornhoff, W. (eds.). 19 ed. München: W. Zuckschwerdt Verlag, p. 95-97 3 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  11. Keimzelltumore

    Honecker, F. U., Bokemeyer, C., Krege, S. & Classen, J., 2018, Taschenbuch Onkologie: Interdisziplinäre Empfehlungen zur Therapie 2018/2019. Honecker, F., Claßen, J., Preiß, J. & Dornhoff, W. (eds.). 19 ed. München: W. Zuckschwerdt Verlag, p. 116-121 6 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  12. Treatment of Metastatic Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE) - Long-Term Disease Control by Multimodal Therapy

    Quidde, J., Alsdorf, W. H., von Amsberg, G., Wilczak, W. & Bokemeyer, C., 2018, In: ONCOL RES TREAT. 41, 1-2, p. 58-60 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Vorwort

    Hallek, M., Bokemeyer, C., Lüftner, D. & Weissinger, F., 2018, In: ONCOL RES TREAT. 41 Suppl 3, p. 1

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Weichteilsarkome

    Kopp, H-G., Bokemeyer, C., Hohenberger, P. & Müller, A-C., 2018, Taschenbuch Onkologie: Interdisziplinäre Empfehlungen zur Therapie 2018/2019. Honecker, F., Claßen, J., Preiß, J. & Dornhoff, W. (eds.). 19 ed. München: W. Zuckschwerdt Verlag, p. 220-229 10 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research

  15. 2017

  16. Neues zum Einsatz von Tumormarkern bei Hodentumoren: Inadäquater Markerabfall und miR-371a-3p

    Oing, C. & Bokemeyer, C., 01.12.2017, In: LEADING OPINIONS Hämatologie & Onkologie. 13, 7, p. 14-15

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  17. Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells

    Dyshlovoy, S. A., Rast, S., Hauschild, J., Otte, K., Alsdorf, W. H., Madanchi, R., Kalinin, V. I., Silchenko, A. S., Avilov, S. A., Dierlamm, J., Honecker, F., Stonik, V. A., Bokemeyer, C. & von Amsberg, G., 12.2017, In: LEUKEMIA LYMPHOMA. 58, 12, p. 2905-2915 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines Panel

    Boormans, J. L., Mayor de Castro, J., Marconi, L., Yuan, Y., Laguna Pes, M. P., Bokemeyer, C., Nicolai, N., Algaba, F., Oldenburg, J. & Albers, P., 20.11.2017, In: EUR UROL.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  19. Das CARE-for-CAYA-Programm. Präventionskonzept für junge Menschen nach Krebserkrankung

    Quidde, J., Koch, B., Salchow, J., Jensen, W., von Grundherr, J., Escherich, G., Rutkowski, S. J., Schulz-Kindermann, F., Bergelt, C., Bokemeyer, C., Sokalska-Duhme, M., Bielak, S., Calaminus, G., Classen, C-F., Rössig, C., Faber, J., Faller, H., Hilgendorf, I., Langer, T., Metzler, M., Schuster, S., Niemeyer, C., Pierce, A., Reinhardt, D., Dirksen, U., Sander, A., Köhler, M. & Stein, A., 23.10.2017, In: Forum. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 32, 06, p. 479-484

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma

    Akyüz, N., Albert-Konetzny, N., Pott, C., Callet-Bauchu, E., Bokemeyer, C., Murga Penas, E. M. & Dierlamm, J., 10.2017, In: LEUKEMIA LYMPHOMA. 58, 10, p. 2480-2484 5 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  21. Versorgung von Patienten nach Krebserkrankung im Kindes-, Jugend- oder jungen Erwachsenenalter

    Quidde, J., Koch, B., Salchow, J., Jensen, W., von Grundherr, J., Escherich, G., Rutkowski, S. J., Schulz-Kindermann, F., Bergelt, C., Bokemeyer, C., Sokalska-Duhme, M., Bielak, S., Calaminus, G., Classen, C-F., Rössig, C., Faber, J., Faller, H., Hilgendorf, I., Langer, T., Metzler, M., Schuster, S., Niemeyer, C., Pierce, A., Reinhardt, D., Dirksen, U., Sander, A., Köhler, M. & Stein, A., 10.2017, In: J Onkol - Z Onkol Fortb. 2017, 10, p. 862-866

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection

    Oberle, A., Brandt, A., Alawi, M., Langebrake, C., Janjetovic, S., Wolschke, C., Schütze, K., Bannas, P., Kröger, N., Koch-Nolte, F., Bokemeyer, C. & Binder, M., 09.2017, In: HAEMATOLOGICA. 102, 9, p. e368-e370

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  23. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

    Wroblewski, M., Bauer, R., Cubas Córdova, M., Udonta, F., Ben-Batalla, I., Legler, K., Hauser, C., Egberts, J., Janning, M., Velthaus, J., Schulze, C., Pantel, K., Bokemeyer, C. & Loges, S., 16.08.2017, In: NAT COMMUN. 8, 1, p. 269

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Neue Aspekte in der Therapie des metastasierten Prostatakarzinoms

    von Amsberg, G. & Bokemeyer, C., 08.2017, In: DEUT MED WOCHENSCHR. 142, 15, p. 1106-1110 5 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  25. Platinum-refractory germ cell tumors: an update on current treatment options and developments

    Oing, C., Alsdorf, W. H., von Amsberg, G., Oechsle, K. & Bokemeyer, C., 08.2017, In: WORLD J UROL. 35, 8, p. 1167-1175

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Testis cancer: some problems still remain unsolved

    Albers, P. & Bokemeyer, C., 08.2017, In: WORLD J UROL. 35, 8, p. 1159-1160 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  27. The Inhibitory Activity of Luzonicosides from the Starfish Echinaster luzonicus against Human Melanoma Cells

    Malyarenko, O. S., Dyshlovoy, S. A., Kicha, A. A., Ivanchina, N. V., Malyarenko, T. V., Carsten, B., Gunhild, V. A., Stonik, V. A. & Ermakova, S. P., 18.07.2017, In: MAR DRUGS. 15, 7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer

    Dulz, S., Asselborn, N. H., Dieckmann, K-P., Matthies, C., Wagner, W., Weidmann, J., Seidel, C., Oing, C., Berger, L. A., Alsdorf, W., Mankichian, B., Meyer, C., Vetterlein, M. W., Gild, P., Ludwig, T. A., Soave, A., Schriefer, P., Becker, A., Ahyai, S. A., Oechsle, K., Bokemeyer, C., Wagenfeld, L., Fisch, M., Hartmann, M., Chun, F. K-H. & Kluth, L. A., 07.2017, In: J CANCER RES CLIN. 143, 7, p. 1319-1325

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database

    Renfro, L. A., Goldberg, R. M., Grothey, A., Sobrero, A., Adams, R., Seymour, M. T., Heinemann, V., Schmoll, H-J., Douillard, J-Y., Hurwitz, H., Fuchs, C. S., Diaz-Rubio, E., Porschen, R., Tournigand, C., Chibaudel, B., Hoff, P. M., Kabbinavar, F. F., Falcone, A., Tebbutt, N. C., Punt, C. J. A., Hecht, J. R., Souglakos, J., Bokemeyer, C., Van Cutsem, E., Saltz, L., de Gramont, A., Sargent, D. J. & ARCAD Clinical Trials Program, 10.06.2017, In: J CLIN ONCOL. 35, 17, p. 1929-1937 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

    Akyüz, N., Brandt, A., Stein, A., Schliffke, S., Mährle, T., Quidde, J., Goekkurt, E., Loges, S., Haalck, T., Ford, C., Asemissen, A. M., Thiele, B., Radloff, J., Thenhausen, T., Krohn-Grimberghe, A., Bokemeyer, C. & Binder, M., 01.06.2017, In: INT J CANCER. 140, 11, p. 2535-2544

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study

    Bokemeyer, C., Gascón, P., Aapro, M., Ludwig, H., Boccadoro, M., Denhaerynck, K., Gorray, M., Krendyukov, A., Abraham, I. & MacDonald, K., 06.2017, In: SUPPORT CARE CANCER. 25, 6, p. 1819-1828

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin

    Dyshlovoy, S. A., Otte, K., Venz, S., Hauschild, J., Junker, H., Makarieva, T. N., Balabanov, S., Alsdorf, W. H., Madanchi, R., Honecker, F., Bokemeyer, C., Stonik, V. A. & von Amsberg, G., 06.2017, In: PROTEOMICS. 17, 11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Quality of life, psychological burden, needs, and satisfaction during specialized inpatient palliative care in family caregivers of advanced cancer patients

    Ullrich, A., Ascherfeld, L., Marx, G., Bokemeyer, C., Bergelt, C. & Oechsle, K., 10.05.2017, In: BMC PALLIAT CARE. 16, 1, p. 31

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia

    Ben Batalla, I., Erdmann, R., Jørgensen, H., Mitchell, R., Ernst, T., von Amsberg, G., Schafhausen, P., Velthaus, J. L., Rankin, S., Clark, R. E., Koschmieder, S., Schultze, A., Mitra, S., Vandenberghe, P., Brümmendorf, T. H., Carmeliet, P., Hochhaus, A., Pantel, K., Bokemeyer, C., Helgason, G. V., Holyoake, T. L. & Loges, S., 01.05.2017, In: CLIN CANCER RES. 23, 9, p. 2289-2300

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Impact of Primary Metastatic Bone Disease in Germ Cell Tumors: Results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study

    Oing, C., Oechsle, K., Necchi, A., Loriot, Y., De Giorgi, U., Fléchon, A., Daugaard, G., Fedyanin, M., Faré, E. & Bokemeyer, C., 01.05.2017, In: ANN ONCOL. 28, 3, p. 576-582

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20]

    Dieckmann, K-P., Radtke, A., Spiekermann, M., Balks, T., Matthies, C., Becker, P., Ruf, C., Oing, C., Oechsle, K., Bokemeyer, C., Hammel, J., Melchior, S., Wosniok, W. & Belge, G., 05.2017, In: EUR UROL. 71, 5, p. e161

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  37. Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

    Harbaum, L., Baaske, K. M., Simon, M., Oqueka, T., Sinning, C., Glatzel, A., Lüneburg, N., Sydow, K., Bokemeyer, C. & Klose, H., 26.04.2017, In: BMC PULM MED. 17, 1, p. 72

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

    Latuske, E-M., Stamm, H., Klokow, M., Vohwinkel, G., Muschhammer, J., Bokemeyer, C., Jücker, M., Kebenko, M., Fiedler, W. & Wellbrock, J., 25.04.2017, In: ONCOTARGET. 8, 17, p. 29187-29201

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-KPolymorphism

    Braig, F., Kriegs, M., Voigtlaender, M., Habel, B., Grob, T., Biskup, K., Blanchard, V., Sack, M., Thalhammer, A., Ben Batalla, I., Braren, I., Laban, S., Danielczyk, A., Goletz, S., Jakubowicz, E., Märkl, B., Trepel, M., Knecht, R., Riecken, K., Fehse, B., Loges, S., Bokemeyer, C. & Binder, M., 01.03.2017, In: CANCER RES. 77, 5, p. 1188-1199 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. The effects of music therapy in patients with high-dose chemotherapy and stem cell support: a randomized pilot study

    Tuinmann, G., Preissler, P., Böhmer, H., Suling, A. & Bokemeyer, C., 03.2017, In: PSYCHO-ONCOLOGY. 26, 3, p. 377-384

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Mutational landscape reflects the biological continuum of plasma cell dyscrasias

    Rossi, A., Voigtländer, M., Janjetovic, S., Thiele, B., Alawi, M., März, M., Brandt, A., Hansen, T., Radloff, J., Schön, G., Hegenbart, U., Schönland, S., Langer, C., Bokemeyer, C. & Binder, M., 24.02.2017, In: BLOOD CANCER J. 7, 2, p. e537

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Cisplatin-refraktäre Keimzelltumoren: Resistenzmechanismen − Therapiestandards − neue Entwicklungen

    Oing, C., Seidel, C., Alsdorf, W. H. & Bokemeyer, C., 01.02.2017, In: ONKOLOGE. 23, 2, p. 123-128 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

    Dyshlovoy, S. A., Madanchi, R., Hauschild, J., Otte, K., Alsdorf, W. H., Schumacher, U., Kalinin, V. I., Silchenko, A. S., Avilov, S. A., Honecker, F., Stonik, V. A., Bokemeyer, C. & von Amsberg, G., 01.02.2017, In: BMC CANCER. 17, 1, p. 93

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Cisplatin-refraktäre Keimzelltumoren: Resistenzmechanismen − Therapiestandards − neue Entwicklungen

    Oing, C., Seidel, C., Alsdorf, W. & Bokemeyer, C., 02.2017, In: ONKOLOGE. 23, 2, p. 123-128 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours

    Dieckmann, K-P., Radtke, A., Spiekermann, M., Balks, T., Matthies, C., Becker, P., Ruf, C., Oing, C., Oechsle, K., Bokemeyer, C., Hammel, J., Melchior, S., Wosniok, W. & Belge, G., 02.2017, In: EUR UROL. 71, 2, p. 213-220

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Kapitel 11 - Tumore des Urogenitaltrakts

    Bokemeyer, C. & Oing, C., 01.2017, Handbuch ONKOLOGIE 2017. 1 ed. Wiesbaden: med publico GmbH, p. 1 - 38

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  47. Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center Analysis

    Thoennissen, G. B., Görlich, D., Bacher, U., Aufenberg, T., Hüsken, A-C., Hansmeier, A. A., Evers, G., Mikesch, J-H., Fritz, F., Bokemeyer, C., Müller-Tidow, C., Stelljes, M., Mesters, R. M., Krug, U., Kropff, M. H., Thoennissen, N. H. & Berdel, W. E., 2017, In: ACTA HAEMATOL-BASEL. 137, 3, p. 163-172 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Immuncheckpointinhibition beim Urothelkarzinom: Pembrolizumab als neuer Therapiestandard in der Zweitlinientherapie?

    Oing, C. & Bokemeyer, C., 2017, In: ONKOLOGE. 23, p. 678-680

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  49. Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.

    Oing, C., Dyshlovoy, S., Burandt, E., Amsberg, G. V., Honecker, F., Bokemeyer, C., Rothkamm, K. & Mansour, W. Y., 2017, In: ONCOL RES TREAT. 40, p. 95-96

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  50. „Neue Substanzen in der Therapie des metastasierten Nierenzellkarzinoms – was, wann und für wen?“: Neuer Tyrosinkinaseinhibitor für die Zweitlinie

    Oing, C. & Bokemeyer, C., 2017, In: InFo Onkologie. 03, p. 12-14

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  51. Self-assessment and Screening for palliative care need in patients with chronic heart failure

    Oechsle, K., Ehlert, J., Kodolitsch, Y., Ullrich, A., Bokemeyer, C. & Rybczynski, M., 2017, In: J PALLIAT CARE. 2017, 7, p. 304

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care

    Iversen, K., Oechsle, K., Oing, C., Bokemeyer, C. & Seidel, C., 2017, In: ONCOL RES TREAT. 40, 10, p. 609-614

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...16 Next